These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 814855)

  • 21. [Preclinical research--toxicology].
    Frohberg H
    Arzneimittelforschung; 1975 Jul; 25(7a):1101-10. PubMed ID: 1242337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The current requirements for the preclinical study of the safety of new drugs].
    Arzamastsev EV; Liubimov BI
    Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306
    [No Abstract]   [Full Text] [Related]  

  • 24. [Organization of the work of the Republican Center for Preclinical Study of New Drugs].
    Sokolova GB; Kunichan AD; Shubin AI
    Probl Tuberk; 1991; (9):27-9. PubMed ID: 1836264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical predictors of clinical safety: opportunities for improvement.
    Sistare FD; DeGeorge JJ
    Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The status of eye irritancy testing: a regulatory perspective.
    Wilcox NL
    Lens Eye Toxic Res; 1992; 9(3-4):259-71. PubMed ID: 1301785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising the design of preliminary toxicity studies for pharmaceutical safety testing in the dog.
    Smith D; Combes R; Depelchin O; Jacobsen SD; Hack R; Luft J; Lammens L; von Landenberg F; Phillips B; Pfister R; Rabemampianina Y; Sparrow S; Stark C; Stephan-Gueldner M
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):95-101. PubMed ID: 15698532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigation of bone marrow in preclinical safety tests of new drugs (author's transl)].
    Berger J
    Cas Lek Cesk; 1982 Jan; 121(4):97-101. PubMed ID: 7060066
    [No Abstract]   [Full Text] [Related]  

  • 29. First dose of potential new medicines to humans: how animals help.
    Greaves P; Williams A; Eve M
    Nat Rev Drug Discov; 2004 Mar; 3(3):226-36. PubMed ID: 15031736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety assessment of drug residues.
    Jackson BA
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1141-4. PubMed ID: 6894293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluations of organ system development in juvenile toxicology testing.
    Robinson K
    Reprod Toxicol; 2008 Sep; 26(1):51-3. PubMed ID: 18595655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA recommendations for preclinical testing of gonadotropin releasing hormone (GnRH) analogues.
    Raheja KL; Jordan A
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):168-75. PubMed ID: 8041914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile animal testing in drug development--is it useful?
    Baldrick P
    Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical safety evaluation of recombinant human interleukin-10.
    Rosenblum IY; Johnson RC; Schmahai TJ
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):56-71. PubMed ID: 11846636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirements of preclinical examinations.
    Lehnert T; Ulbrich B
    Lens Eye Toxic Res; 1990; 7(3-4):207-19. PubMed ID: 2100159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical safety profile of alendronate.
    Peter C; Rodan GA
    Int J Clin Pract Suppl; 1999 Apr; 101():3-8. PubMed ID: 12669734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.